Noah Davidsohn

Executive Officer, Director at Rejuvenate Bio.

Raised on Rejuvenate Bio filings

$19.5M

of $27M offered across 1 Form D filing

Company

Biotech · San Diego, CA

Gene therapies for age-related disease in dogs and people

Gene therapies for age-related disease in dogs and people

Rejuvenate Bio Form D filings
Filed	Security	Sold of offered	Filing
Jun 18, 2026	Equity	$19.5M/ $27M	Form D

Also named on Rejuvenate Bio filings